2021
DOI: 10.3390/hearts2010007
|View full text |Cite
|
Sign up to set email alerts
|

Percutaneous Mitral Valve Repair with the MitraClip System in the Current Clinical Practice

Abstract: Severe mitral valve regurgitation (MR) carries a significant burden both in prognosis and quality of life of patients, as well as on healthcare systems, with high rates of hospitalization for heart failure. While mitral valve surgery constitutes the first-line treatment option for primary MR in suitable patients, surgical treatment for secondary severe MR remains controversial, with a substantial lack of evidence on a survival benefit. In recent decades, percutaneous mitral valve repair has emerged as an alter… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 54 publications
(67 reference statements)
0
2
0
Order By: Relevance
“…Moreover, percutaneous approaches for MV repair have emerged as a valid alternative to openchest MV surgery. Among the available approaches, transcatheter edge-to-edge repair (TEER) is the most widespread one and is supported by the strongest evidence [13]. According to the guidelines of the European Society of Cardiology (ESC) [14] and the American Heart Association (AHA) [15], transthoracic echocardiography (TTE) is the standard imaging modality to diagnose and quantify MR, while transesophageal echocardiography (TEE) is used for morphologic assessment of pathologic MV and to guide MV procedures.…”
Section: Introductionmentioning
confidence: 99%
“…Moreover, percutaneous approaches for MV repair have emerged as a valid alternative to openchest MV surgery. Among the available approaches, transcatheter edge-to-edge repair (TEER) is the most widespread one and is supported by the strongest evidence [13]. According to the guidelines of the European Society of Cardiology (ESC) [14] and the American Heart Association (AHA) [15], transthoracic echocardiography (TTE) is the standard imaging modality to diagnose and quantify MR, while transesophageal echocardiography (TEE) is used for morphologic assessment of pathologic MV and to guide MV procedures.…”
Section: Introductionmentioning
confidence: 99%
“…Recently, atrial functional mitral regurgitation (aFMR) has been increasingly recognized and is characterized by severe mitral annular dilatation, insufficient leaflet remodeling and decreased annular contractility in patients with longstanding atrial fibrillation (AF) [5]. Clinically, different treatment methods are adopted for different types of MR [6,7].…”
Section: Introductionmentioning
confidence: 99%